1
|
He G, Zheng Y, Chang S, Wang L, Yang X, Hao H, Li J, Zhang X, Tian F, Liang X, Xu H, Wang P, Chen X, Cao Z, Fang S, Gao Z, Liu H. Discovery of Novel Pyrimidine-Based Derivatives as Nav1.2 Inhibitors with Efficacy in Mouse Models of Epilepsy. J Med Chem 2024. [PMID: 39037114 DOI: 10.1021/acs.jmedchem.4c00861] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/23/2024]
Abstract
Dysfunction of voltage-gated sodium channel Nav1.2 causes various epileptic disorders, and inhibition of the channel has emerged as an attractive therapeutic strategy. However, currently available Nav1.2 inhibitors exhibit low potency and limited structural diversity. In this study, a novel series of pyrimidine-based derivatives with Nav1.2 inhibitory activity were designed, synthesized, and evaluated. Compounds 14 and 35 exhibited potent activity against Nav1.2, boasting IC50 values of 120 and 65 nM, respectively. Compound 14 displayed favorable pharmacokinetics (F = 43%) following intraperitoneal injection and excellent brain penetration potency (B/P = 3.6). Compounds 14 and 35 exhibited robust antiepileptic activities in the maximal electroshock test, with ED50 values of 3.2 and 11.1 mg/kg, respectively. Compound 35 also demonstrated potent antiepileptic activity in a 6 Hz (32 mA) model, with an ED50 value of 18.5 mg/kg. Overall, compounds 14 and 35 are promising leads for the development of new small-molecule therapeutics for epilepsy.
Collapse
Affiliation(s)
- Guoxue He
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Yueming Zheng
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Shunzhen Chang
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Long Wang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- Pharmacophenomics Laboratory, Human Phenome Institute, Fudan University, Shanghai 201203, China
| | - Xiaohao Yang
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Haishuang Hao
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Jiyuan Li
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China
| | - Xian Zhang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Fuyun Tian
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Xuewu Liang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Haiyan Xu
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Pei Wang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Xueqin Chen
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Zeyu Cao
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
- University of Chinese Academy of Sciences, Beijing 100049, China
| | - Sui Fang
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Zhaobing Gao
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences, Beijing 100049, China
- Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
| | - Hong Liu
- School of Pharmaceutical Science and Technology, Hangzhou Institute for Advanced Study, University of Chinese Academy of Sciences, Hangzhou 310024, China
- State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
- University of Chinese Academy of Sciences, Beijing 100049, China
- School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing 210023, China
| |
Collapse
|
2
|
Abd-Allah WH, El-Mohsen Anwar MA, Mohammed ER, El Moghazy SM. Anticonvulsant Classes and Possible Mechanism of Actions. ACS Chem Neurosci 2023; 14:4076-4092. [PMID: 37948544 DOI: 10.1021/acschemneuro.3c00613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2023] Open
Abstract
Epilepsy is considered one of the most common neurological disorders worldwide; it needs long-term or life-long treatment. Despite the presence of several novel antiepileptic drugs, approximately 30% patients still suffer from drug-resistant epilepsy. Subsequently, searching for new anticonvulsants with lower toxicity and better efficacy is still in paramount demand. Using target-based studies in the discovery of novel antiepileptics is uncommon owing to the insufficient information on the molecular pathway of epilepsy and complex mode of action for most of known antiepileptic drugs. In this review, we investigated the properties of anticonvulsants, types of epileptic seizures, and mechanism of action for anticonvulsants.
Collapse
Affiliation(s)
- Walaa Hamada Abd-Allah
- Pharmaceutical Chemistry Department, Collage of Pharmaceutical Science and Drug Manufacturing, Misr University for Science and Technology, P.O. 77, 12568 6th of October City, Giza, Egypt
| | - Mostafa Abd El-Mohsen Anwar
- Pharmaceutical Chemistry Department, Collage of Pharmaceutical Science and Drug Manufacturing, Misr University for Science and Technology, P.O. 77, 12568 6th of October City, Giza, Egypt
| | - Eman R Mohammed
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, 11562 Cairo, Egypt
| | - Samir M El Moghazy
- Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Cairo University, 11562 Cairo, Egypt
| |
Collapse
|
3
|
Treating of focal epilepsy: a patent review. Pharm Pat Anal 2021; 10:165-173. [PMID: 34076528 DOI: 10.4155/ppa-2021-0008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Focal epilepsy is one of the most frequent specific type of epilepsies, with 30% treatment-resistant patients. There are several directions researchers can follow to improve existing treatment of focal epilepsy: synthesis of new compounds with anticonvulsant activity, repurposing drugs approved for other indications, finding drugs targeted to specific genetic and biochemical defects that underlie focal epilepsy syndromes, development of viral vectors for specific gene therapy, creation of devices and methods for suppression of seizures by electrostimulation and development of methods to increase safety of epilepsy surgery. Improvement of efficacy and safety of current therapies is necessary, as well as developing targeted treatment of genetic epilepsy syndromes that will not only suppress seizures, but stop further epileptogenesis.
Collapse
|
4
|
Hema M, ArunRenganathan R, Nanjundaswamy S, Karthik C, Mohammed YHI, Alghamdi S, Lokanath N, Ravishankar Rai V, Nagashree S, Mallu P. N-(4-bromobenzylidene)-2,3-dihydrobenzo[b][1,4]dioxin-6-amine: Synthesis, crystal structure, docking and in-vitro inhibition of PLA2. J Mol Struct 2020. [DOI: 10.1016/j.molstruc.2020.128441] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
|
5
|
Xiong X, Mao YJ, Hao HY, He YT, Xu ZY, Luo G, Lou SJ, Xu DQ. Nitrate promoted mild and versatile Pd-catalysed C(sp 2)-H oxidation with carboxylic acids. Org Biomol Chem 2020; 18:6732-6737. [PMID: 32832956 DOI: 10.1039/d0ob01124j] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A nitrate-promoted Pd-catalysed mild cross-dehydrogenative C(sp2)-H bond oxidation of oximes or azobenzenes with diverse carboxylic acids has been developed. In contrast to the previous catalytic systems, this protocol features mild conditions (close to room temperature for most cases) and a broad substrate scope (up to 64 examples), thus constituting a versatile method to directly prepare diverse O-aryl esters. Moreover, the superiority of the nitrate additive in this mild transformation was further determined by experimental and computational evidence.
Collapse
Affiliation(s)
- Xue Xiong
- College of Chemical Engineering, Catalytic Hydrogenation Research Center, State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Key Laboratory of Green Pesticides and Cleaner Production Technology of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, P. R. China.
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Li L, Song F, Zhong X, Wu Y, Zhang X, Chen J, Huang Y. Ligand‐Controlled C−O Bond Coupling of Carboxylic Acids and Aryl Iodides: Experimental and Computational Insights. Adv Synth Catal 2020. [DOI: 10.1002/adsc.201901136] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Affiliation(s)
- Li Li
- State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical GenomicsPeking University, Shenzhen Graduate School Shenzhen 518055 China
| | - Feifei Song
- State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical GenomicsPeking University, Shenzhen Graduate School Shenzhen 518055 China
| | | | - Yun‐Dong Wu
- State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical GenomicsPeking University, Shenzhen Graduate School Shenzhen 518055 China
- Shenzhen Bay Laboratory Shenzhen 518055 China
| | - Xinhao Zhang
- State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical GenomicsPeking University, Shenzhen Graduate School Shenzhen 518055 China
- Shenzhen Bay Laboratory Shenzhen 518055 China
| | - Jiean Chen
- State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical GenomicsPeking University, Shenzhen Graduate School Shenzhen 518055 China
- Shenzhen Bay Laboratory Shenzhen 518055 China
| | - Yong Huang
- State Key Laboratory of Chemical Oncogenomics, Key Laboratory of Chemical GenomicsPeking University, Shenzhen Graduate School Shenzhen 518055 China
- Department of ChemistryThe Hong Kong University of Science of Technology Clear Water Bay Kowloon
| |
Collapse
|
7
|
Design and synthesis of novel parabanic acid derivatives as anticonvulsants. Bioorg Chem 2020; 94:103473. [DOI: 10.1016/j.bioorg.2019.103473] [Citation(s) in RCA: 9] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2019] [Revised: 10/21/2019] [Accepted: 11/23/2019] [Indexed: 12/15/2022]
|
8
|
Penteado F, Monti B, Sancineto L, Perin G, Jacob RG, Santi C, Lenardão EJ. Ultrasound‐Assisted Multicomponent Reactions, Organometallic and Organochalcogen Chemistry. ASIAN J ORG CHEM 2018. [DOI: 10.1002/ajoc.201800477] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Affiliation(s)
- Filipe Penteado
- Laboratório de Síntese Orgânica Limpa – LASOL –Universidade Federal de Pelotas – UFPel – P.O. Box 354 96010-900 Pelotas (RS) Brazil
| | - Bonifacio Monti
- Department of Pharmaceutical Sciences –University of Perugia - Via del Liceo, 1 Perugia (PG) Italy
| | - Luca Sancineto
- Centre of Molecular and Macromolecular StudiesPolish Academy of Sciences, Sienkiewicza 112 90-363 Łódź Poland
| | - Gelson Perin
- Laboratório de Síntese Orgânica Limpa – LASOL –Universidade Federal de Pelotas – UFPel – P.O. Box 354 96010-900 Pelotas (RS) Brazil
| | - Raquel G. Jacob
- Laboratório de Síntese Orgânica Limpa – LASOL –Universidade Federal de Pelotas – UFPel – P.O. Box 354 96010-900 Pelotas (RS) Brazil
| | - Claudio Santi
- Department of Pharmaceutical Sciences –University of Perugia - Via del Liceo, 1 Perugia (PG) Italy
| | - Eder J. Lenardão
- Laboratório de Síntese Orgânica Limpa – LASOL –Universidade Federal de Pelotas – UFPel – P.O. Box 354 96010-900 Pelotas (RS) Brazil
| |
Collapse
|
9
|
Yin X, Huang Y, Chen Z, Hu Y, Tao L, Zhao Q, Dong XQ, Zhang X. Enantioselective Access to Chiral 2-Substituted 2,3-Dihydrobenzo[1,4]dioxane Derivatives through Rh-Catalyzed Asymmetric Hydrogenation. Org Lett 2018; 20:4173-4177. [PMID: 29968478 DOI: 10.1021/acs.orglett.8b01469] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/28/2022]
Abstract
Rh-catalyzed asymmetric hydrogenation of various benzo[ b][1,4]dioxine derivatives was successfully developed to prepare chiral 2-substituted 2,3-dihydrobenzo[1,4]dioxane derivatives using ZhaoPhos and N-methylation of ZhaoPhos ligands with high yields and excellent enantioselectivities (up to 99% yield, >99% enantiomeric excess (ee), turnover number (TON) = 24 000). Moreover, this asymmetric hydrogenation methodology, as the key step with up to 10 000 TON, was successfully applied to develop highly efficient synthetic routes for the construction of some important biologically active molecules, such as MKC-242, WB4101, BSF-190555, and ( R)-doxazosin·HCl.
Collapse
Affiliation(s)
- Xuguang Yin
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China
| | - Yi Huang
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China
| | - Ziyi Chen
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China
| | - Yang Hu
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China
| | - Lin Tao
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China
| | - Qingyang Zhao
- Key Laboratory of Synthetic and Natural Functional Molecule, Chemistry of Ministry of Education, College of Chemistry and Materials Science , Northwest University , Xi'an , People's Republic of China
| | - Xiu-Qin Dong
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China
| | - Xumu Zhang
- Key Laboratory of Biomedical Polymers, Engineering Research Center of Organosilicon Compounds & Materials, Ministry of Education, College of Chemistry and Molecular Sciences , Wuhan University , Wuhan , Hubei 430072 , People's Republic of China.,Department of Chemistry , Southern University of Science and Technology , Shenzhen , Guangdong 518055 , People's Republic of China
| |
Collapse
|
10
|
Grib I, Belhani B, Bechlem K, Bouasla R, Aouf NE, Berredjem M. Ultrasonic assisted green protocol for the synthesis of sulfamides. PHOSPHORUS SULFUR 2017. [DOI: 10.1080/10426507.2017.1287184] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Affiliation(s)
- Ismahene Grib
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modeling Group, Badji-Mokhtar, Annaba University, Annaba, Algeria
| | - Billel Belhani
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modeling Group, Badji-Mokhtar, Annaba University, Annaba, Algeria
| | - Khaoula Bechlem
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modeling Group, Badji-Mokhtar, Annaba University, Annaba, Algeria
| | - Radia Bouasla
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modeling Group, Badji-Mokhtar, Annaba University, Annaba, Algeria
| | - Nour-Eddine Aouf
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modeling Group, Badji-Mokhtar, Annaba University, Annaba, Algeria
| | - Malika Berredjem
- Laboratory of Applied Organic Chemistry, Synthesis of Biomolecules and Molecular Modeling Group, Badji-Mokhtar, Annaba University, Annaba, Algeria
| |
Collapse
|
11
|
Ab Initio Calculations on some Antiepileptic Drugs such as Phenytoin, Phenbarbital, Ethosuximide and Carbamazepine. Struct Chem 2016. [DOI: 10.1007/s11224-016-0898-3] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
|
12
|
Villalba ML, Enrique AV, Higgs J, Castaño RA, Goicoechea S, Taborda FD, Gavernet L, Lick ID, Marder M, Bruno Blanch LE. Novel sulfamides and sulfamates derived from amino esters: Synthetic studies and anticonvulsant activity. Eur J Pharmacol 2016; 774:55-63. [DOI: 10.1016/j.ejphar.2016.02.001] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/04/2015] [Revised: 01/30/2016] [Accepted: 02/01/2016] [Indexed: 12/22/2022]
|
13
|
Do traditional anti-seizure drugs have a future? A review of potential anti-seizure drugs in clinical development. Pharmacol Res 2016; 104:38-48. [DOI: 10.1016/j.phrs.2015.12.011] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 11/16/2015] [Revised: 12/08/2015] [Accepted: 12/08/2015] [Indexed: 12/11/2022]
|
14
|
Discovery of potent carbonic anhydrase and acetylcholine esterase inhibitors: Novel sulfamoylcarbamates and sulfamides derived from acetophenones. Bioorg Med Chem 2015; 23:3592-602. [DOI: 10.1016/j.bmc.2015.04.019] [Citation(s) in RCA: 120] [Impact Index Per Article: 13.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/11/2015] [Revised: 04/07/2015] [Accepted: 04/08/2015] [Indexed: 11/22/2022]
|
15
|
Gediz Erturk A, Bekdemir Y. Acid-catalyzed hydrolysis of 5-substituted-1 H,3 H-2,1,3-benzothiadiazole 2,2-dioxides (5-substituted benzosulfamides): kinetic behavior and mechanistic interpretations. J PHYS ORG CHEM 2015. [DOI: 10.1002/poc.3419] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
Affiliation(s)
- Aliye Gediz Erturk
- Department of Chemistry, Faculty of Science and Arts; Ordu University - Cumhuriyet Campus; 52200 Ordu Turkey
| | - Yunus Bekdemir
- Department of Molecular Biology and Genetics, Faculty of Science and Arts; Canik Basari University - Gurgenyatak Campus; 55080 Canik/Samsun Turkey
| |
Collapse
|
16
|
Shi J, Wang T, Huang Y, Zhang X, Wu YD, Cai Q. Pd-Catalyzed Asymmetric Intramolecular Aryl C–O Bond Formation with SDP(O) Ligand: Enantioselective Synthesis of (2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)methanols. Org Lett 2015; 17:840-3. [DOI: 10.1021/ol5036613] [Citation(s) in RCA: 35] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Affiliation(s)
- Jialing Shi
- Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, No. 190 Kaiyuan Avenue, Guangzhou Science Park, Guangzhou, 510530, China
- College
of Chemistry and Chemical Engineering, Hunan Normal University, No.
36 Lushan Road, Changsha, 410081, China
| | - Ting Wang
- Laboratory
of Computational Chemistry and Drug Design, Key Laboratory of Chemical
Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China
| | - Yusha Huang
- Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, No. 190 Kaiyuan Avenue, Guangzhou Science Park, Guangzhou, 510530, China
- ShenYang Pharmaceutical University, No. 103 Wenhua Road, Shenhe Fistrict, Shenyang, 110016, China
| | - Xinhao Zhang
- Laboratory
of Computational Chemistry and Drug Design, Key Laboratory of Chemical
Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China
| | - Yun-Dong Wu
- Laboratory
of Computational Chemistry and Drug Design, Key Laboratory of Chemical
Genomics, Peking University Shenzhen Graduate School, Shenzhen 518055, China
| | - Qian Cai
- Guangzhou
Institutes of Biomedicine and Health, Chinese Academy of Sciences, No. 190 Kaiyuan Avenue, Guangzhou Science Park, Guangzhou, 510530, China
| |
Collapse
|
17
|
Abstract
The anticonvulsant topiramate not only decreases ethanol consumption in alcohol dependence (AD) but also may produce several adverse events including cognitive impairment. Zonisamide is a structurally related anticonvulsant that is a promising agent for the treatment of AD and may have greater tolerability than topiramate. This study evaluated the effects of zonisamide (400 mg/d) on alcohol consumption and its neurotoxic effects in subjects with AD. A double-blind placebo-controlled clinical trial was conducted using 2 comparator anticonvulsant drugs, topiramate (300 mg/d) and levetiracetam (2000 mg/d), which does not impair cognition. Study medications were administered for 14 weeks, including a 2-week taper period. Medication adherence was facilitated using Brief Behavioral Compliance Enhancement Treatment. The neurotoxicity of the study drugs was assessed using neuropsychological tests and the AB-Neurotoxicity Scale. Compared with placebo, both zonisamide and topiramate produced significant reductions in the drinks consumed per day, percent days drinking, and percent days heavy drinking. Only the percent days heavy drinking was significantly decreased in the levetiracetam group. The topiramate cell was the only group that had a significant increase on the mental slowing subscale of the Neurotoxicity Scale compared with placebo at study weeks 11 and 12. Topiramate and zonisamide both produced modest reductions in verbal fluency and working memory. These findings indicate that zonisamide may have efficacy in the treatment of AD, with effect sizes similar to topiramate. Both of these drugs produced similar patterns of cognitive impairment, although only the topiramate group reported significant increases in mental slowing.
Collapse
|
18
|
Eichenbaum G, Zhou J, Kelley M, Roosen W, Costa-Giomi P, Louden C, Di Prospero N, Pandina G, Singh J, Ford L, Moyer J, Nork T, Ver Hoeve J, Aguirre G. Implications of retinal effects observed in chronic toxicity studies on the clinical development of a CNS-active drug candidate. Regul Toxicol Pharmacol 2014; 69:187-200. [DOI: 10.1016/j.yrtph.2014.03.005] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/09/2014] [Revised: 03/15/2014] [Accepted: 03/17/2014] [Indexed: 11/25/2022]
|
19
|
Burtea A, Salzameda NT. Discovery and SAR study of a sulfonamide hydroxamic acid inhibitor for the botulinum neurotoxin serotype A light chain. MEDCHEMCOMM 2014. [DOI: 10.1039/c4md00053f] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Through the use of chemical synthesis and high throughput screening, we discovered a sulfonamide hydroxamic acid inhibitor for the botulinum neurotoxin serotype A light chain. A structure activity relationship study of the parent inhibitor resulted in the synthesis of a new inhibitor with an IC50of 0.95 ± 0.60 μM for the BoNT/A LC.
Collapse
Affiliation(s)
- Alexander Burtea
- Department of Chemistry & Biochemistry
- California State University
- Fullerton, USA
| | | |
Collapse
|